Charles Mathews serves as Executive at AVANIR PHARMACEUTICALS, where they oversee executive responsibilities. Since joining the company, Charles Mathews has executed 15 insider transactions totaling $38.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 9, 2016 involved exercising options for 3,485 shares valued at $0.
Charles Mathews currently holds 19,916 shares of AVANIR PHARMACEUTICALS (AVN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Charles Mathews has been a net buyer of AVN stock. They have purchased $38.4K and sold $0 worth of shares.
Charles Mathews's most recent insider trade was on Mar 9, 2016, when they sold 3,485 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| 5,715 |
| $N/A |
| Discretionary |
| Feb 10, 2014 | LPTN | $0 | Option Exercise | 2,858 | $N/A | Discretionary |
| Dec 19, 2012 | LPTN | $24.9K | Purchase | 5,000 | $4.98 | Discretionary |
| Nov 20, 2012 | LPTN | $0 | Option Exercise | 2,858 | $N/A | Discretionary |
| Mar 6, 2012 | AVNR | $13.4K | Purchase | 5,000 | $2.69 | Discretionary |
| Feb 16, 2012 | AVNR | $0 | Award | 30,000 | $N/A | Discretionary |
| Feb 8, 2011 | AVNR | $0 | Award | 30,000 | $N/A | Discretionary |
| Feb 18, 2010 | AVNR | $0 | Award | 40,000 | $N/A | Discretionary |
| Feb 18, 2010 | AVNR | $0 | Award | 40,000 | $N/A | Discretionary |
| Feb 19, 2009 | AVNR | $0 | Award | 60,000 | $N/A | Discretionary |
| Feb 21, 2008 | AVNR | $0 | Award | 56,911 | $N/A | Discretionary |
| Mar 1, 2007 | AVNR | $0 | Award | 32,496 | $N/A | Discretionary |
| Mar 1, 2007 | AVNR | $0 | Award | 11,752 | $N/A | Discretionary |
| Feb 13, 2006 | AVN | $0 | Award | 6,435 | $N/A | Discretionary |